[EN] Background: Platinum doublets are standard chemotherapy for advanced non-small-cell lung cancer (NSCLC). The aim of this study was to assess whether neutropenia is: (1) an indicator for treatment efficacy, or (2) ...
Bodí, Vicente; Rumiz, Eva; Merlos, Pilar; Nunez, Julio; Lopez-Lereu, Maria P.; Monmeneu, José V.; Chaustre Mendoza, Luis Fabián; Moratal Pérez, David; Trapero, Isabel; Blasco, Maria L.; Oltra, Ricardo; Sanjuán, Rafael; Chorro, Francisco J.; Llàcer, Àngel; Sanchis, Juan(Elsevier, 2011)
[EN] Introduction and objectives: Pharmacoinvasive strategy represents an attractive alternative to primary angioplasty. Using cardiovascular magnetic resonance imaging we compared the left ventricular outcome of the ...
[EN] Background: In advanced-stage (IIIB or IV) non-small-cell lung cancer (NSCLC), combination chemotherapy has demonstrated response rates of 20% and a 1-year survival rate of 30%. We conducted a multicentre, open-label, ...